Evidence map›Paper›PMID 27065804›Full record

ArticleFrontiers in cellular neuroscience2016

Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits.

Peter Falkai, Johann Steiner, Berend Malchow, Jawid Shariati, Andreas Knaus, Hans-Gert Bernstein, Thomas Schneider-Axmann, Theo Kraus, Alkomiet Hasan, Bernhard Bogerts and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Pooled it
  3. Trial
  4. Trial
  5. The role ofEpigenetics · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cellular pathology in the limbic system in schizophrenia.European archives of psychiatry and clinical neuroscience · 2023
    Article
  16. Review
  17. Article
  18. Activation of AExperimental and therapeutic medicine · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Peter FalkaiDepartment of Psychiatry and Psychotherapy, Ludwig Maximilians-University Munich Munich, Germany.
Johann SteinerDepartment of Psychiatry and Psychotherapy, University of Magdeburg Magdeburg, Germany.
Berend MalchowDepartment of Psychiatry and Psychotherapy, Ludwig Maximilians-University Munich Munich, Germany.
Jawid ShariatiDepartment of Psychiatry and Psychotherapy, University of Göttingen Göttingen, Germany.
Andreas KnausDepartment of Psychiatry and Psychotherapy, University of Göttingen Göttingen, Germany.
Hans-Gert BernsteinDepartment of Psychiatry and Psychotherapy, University of Magdeburg Magdeburg, Germany.
Thomas Schneider-AxmannDepartment of Psychiatry and Psychotherapy, Ludwig Maximilians-University Munich Munich, Germany.
Theo KrausCenter for Neuropathology and Prion Research (ZNP), Ludwig Maximilians-University Munich Munich, Germany.
Alkomiet HasanDepartment of Psychiatry and Psychotherapy, Ludwig Maximilians-University Munich Munich, Germany.
Bernhard BogertsDepartment of Psychiatry and Psychotherapy, University of Magdeburg Magdeburg, Germany.
Andrea SchmittDepartment of Psychiatry and Psychotherapy, Ludwig Maximilians-University MunichMunich, Germany; Laboratory of Neuroscience (LIM27), Institute of Psychiatry, University of São PauloSão Paulo, Brazil.
Ludwig-Maximilians-Universität München · DEUniversity Hospital Magdeburg · DEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In schizophrenia, previous stereological post-mortem investigations of anterior, posterior, and total hippocampal subfields showed no alterations in total neuron number but did show decreased oligodendrocyte numbers in CA4, an area that corresponds to the polymorph layer of the dentate gyrus (DG). However, these investigations identified oligodendrocytes only on the basis of morphological criteria in Nissl staining and did not assess alterations of interneurons with immunohistochemical markers. Moreover, the association of findings in the posterior hippocampus with cognitive deficits remains unknown. On the basis of the available clinical records, we compared patients with definite and possible cognitive dysfunction; nine patients had evidence in their records of either definite (n = 4) or possible (n = 5) cognitive dysfunction. Additionally, we assessed the density of two oligodendrocyte subpopulations immunostained by the oligodendrocyte transcription factors Olig1 and Olig2 and of interneurons immunolabeled by parvalbumin. We investigated posterior hippocampal subregions in the post-mortem brains of the same schizophrenia patients (SZ; n = 10) and healthy controls (n = 10) we examined in our previously published stereological studies. Our stereological studies found that patients with definite cognitive deficits had decreased total/Nissl-stained oligodendrocyte numbers in the left (p = 0.014) and right (p = 0.050) CA4, left CA2/3 (p = 0.050), left CA1 (p = 0.027), and left (p = 0.050) and right (p = 0.014) subiculum of the anterior part of the hippocampus compared to patients with possible cognitive deficits. In the present study, we found no significant influence of definite cognitive deficits in the posterior part of the hippocampus, whereas in the entire hippocampus SZ with definite cognitive deficits showed decreased oligodendrocyte numbers in the left (p = 0.050) and right (p = 0.050) DG and left CA2/3 (p = 0.050). We did not find significant differences in Olig1-, Olig2-, or parvalbumin-positive cell density between SZ and controls in any of the subregions of the posterior hippocampus. Based on the results from our stereological study we hypothesize that a decreased number of oligodendrocytes in the anterior and entire hippocampus may be involved in cognitive deficits by impairing the connectivity of this structure in schizophrenia. In the posterior hippocampus, we could not replicate previously reported findings of decreased interneurons from the entire hippocampus.

Indexed as

cognitionhippocampusimmunohistochemistryinterneuronsoligodendrocytespost-mortemschizophrenia

Identifiers

PMID27065804
PMCPMC4811909
OpenAlexW2320835301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.